首页> 外文期刊>The journal of sexual medicine >Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations.
【24h】

Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations.

机译:伐地那非起效时间:对口分散性和薄膜包衣片剂的关键试验的回顾性分析。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Patients and physicians consider a rapid onset of action to be an important attribute of oral pharmacotherapy for erectile dysfunction. AIM: To investigate the time to onset of action of a new orodispersible tablet (ODT) formulation of vardenafil. METHODS: A post hoc integrated analysis was performed on data from two 12-week, double-blind, multicenter, randomized, parallel-group, placebo-controlled phase III trials of 10 mg vardenafil ODT. Data for the vardenafil film-coated tablet were generated from a retrospective integrated analysis at week 12 of four double-blind, multicenter, randomized, parallel-group, fixed-dose, placebo-controlled phase III trials. Time intervals (in 15-, 30-, and 60-minute increments, up to >/=6 hours after study medication intake) were determined for the period between dosing and start of sexual activity (with the intention of intercourse). MAIN OUTCOME MEASURES: The total number of sexual intercourse attempts and Sexual Encounter Profile question 3 (SEP3) success rates were calculated per time interval. RESULTS: Within 15 minutes postdosing, mean per-patient SEP3 success rates were 62.5% (vardenafil ODT) vs. 29.4% (placebo), with corresponding overall SEP3 success rates of 59.8% and 38.2%. In this time interval, 5.3% vs. 2.8% of all sexual activity attempts were initiated by subjects taking vardenafil ODT (n = 89) or placebo (n = 62), respectively. At 16-30 minutes postdosing, SEP3 success rates were 65.3% and 32.6% (mean per-patient) and 70.2% and 51.0% (overall) for vardenafil ODT vs. placebo, respectively, with a corresponding 10.4% and 8.7% of all sexual activity attempts being made by subjects taking vardenafil ODT (n = 170) or placebo (n = 118). Comparable results were observed for vardenafil 10 and 20 mg film-coated tablet at corresponding time intervals. CONCLUSIONS: Vardenafil ODT shows a rapid onset of action comparable with that of vardenafil film-coated tablet. In those men who begin sexual activity within 30 minutes after dosing, the majority of sexual attempts lead to successful intercourse.
机译:简介:患者和医生认为起效迅速是口服药物治疗勃起功能障碍的重要属性。目的:研究伐地那非新的口服分散片(ODT)制剂起效时间。方法:对来自10份伐地那非ODT的两项12周,双盲,多中心,随机,平行组,安慰剂对照的III期临床试验的数据进行事后综合分析。伐地那非薄膜衣片的数据是在第12周对四项双盲,多中心,随机,平行组,固定剂量,安慰剂对照的III期临床试验进行回顾性综合分析后得出的。确定给药和开始性行为之间的时间间隔(以服用研究药物后> / = 6小时,以15分钟,30分钟和60分钟为增量)。主要观察指标:计算每个时间间隔的性交尝试总数和性接触测验问题3(SEP3)成功率。结果:给药后15分钟内,每位患者SEP3的平均成功率为62.5%(vardenafil ODT),而安慰剂为29.4%(相对应),相应的总体SEP3成功率为59.8%和38.2%。在这段时间间隔内,分别由服用伐地那非ODT(n = 89)或安慰剂(n = 62)的受试者发起了所有性活动尝试的5.3%和2.8%。给药后16-30分钟,伐地那非ODT与安慰剂的SEP3成功率分别为65.3%和32.6%(平均每位患者)以及70.2%和51.0%(总体),分别占全部的10.4%和8.7%服用伐地那非ODT(n = 170)或安慰剂(n = 118)的受试者试图进行性活动。在相应的时间间隔观察到伐地那非10和20 mg薄膜衣片的可比结果。结论:伐地那非ODT的起效迅速,与伐地那非薄膜衣片相当。在服药后30分钟内开始性行为的那些男人中,大多数性尝试都会导致成功的性交。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号